OTC · BFNH

Bioforce Nanosciences Holdings, Inc.

Closing price No closing price on file for BFNH from our free price source.

Latest quarter · ended Sep 30, 2026

Cash got weaker

descriptionFiled Nov 9, 2026
Cash from operationsWorse
−$94.8K
Quarter ended Dec 31, 2024: −$14.8K cash from operationsQuarter ended Mar 31, 2025: −$15.2K cash from operationsQuarter ended Jun 30, 2025: −$27.9K cash from operationsQuarter ended Sep 30, 2025: −$11.1K cash from operationsQuarter ended Dec 31, 2025: −$10.9K cash from operationsQuarter ended Mar 31, 2026: $7.09K cash from operationsQuarter ended Jun 30, 2026: −$27K cash from operationsQuarter ended Sep 30, 2026: −$94.8K cash from operations
Dec '24Sep '26
vs. −$11.1K a year ago
Share countDiluting
+13.6%
Quarter ended Dec 31, 2024: 33.52M sharesQuarter ended Mar 31, 2025: 33.52M sharesQuarter ended Jun 30, 2025: 33.52M sharesQuarter ended Sep 30, 2025: 33.52M sharesQuarter ended Dec 31, 2025: 33.52M sharesQuarter ended Mar 31, 2026: 33.52M sharesQuarter ended Jun 30, 2026: 33.55M sharesQuarter ended Sep 30, 2026: 38.07M shares
Dec '24Sep '26
38.07M shares vs. 33.52M a year ago

Numbers come from the company's own 10-Q and 10-K reports filed with the SEC. Each bar is one quarter, oldest on the left. The colored bar is the latest. Hover over or tap a bar to see its number.

Smart money pulse

What insiders and funds are doing

Mixed Insiders: as of Nov 13
−1000+100 0
  • info
    1 real insider sale in 12 months. $534K in total, not counting planned sales.

−100 means everyone selling, +100 everyone buying. This is data, not advice.

How the Pulse works

Pulse runs from −100 (everyone selling) to +100 (everyone buying). Half comes from insiders: real buyers vs. real sellers in the last 90 days (Form 4). Half comes from funds: funds that bought vs. funds that sold last quarter (13F). 13F is a snapshot of long positions on the last day of the quarter, filed up to 45 days later. It does not show short positions or trades since then.

Insider trades · last 12 months

Real buys and sales

● Open-market buy● Open-market sale
CEOCFOOther officersDirectorsDecJanFebMarAprMayJunJulAugSepOctNovGift · Apr 20 · $206KGift · Apr 20 · 4.13M shCode J · Aug 20 · $25KStock grant · Aug 31 · $174KOpen-market sale · Apr 22 · $534K
CEOCFOOther officersDirectorsDecFebAprJunAugOctGift · Apr 20 · $206KGift · Apr 20 · 4.13M shCode J · Aug 20 · $25KStock grant · Aug 31 · $174KOpen-market sale · Apr 22 · $534K

Last 12 months. No real trades in the last 6.

Showing 1 real trade. Hidden: 1 stock grant, 2 gifts. Those happen on a schedule and say little about what an insider thinks. Bigger dot means a bigger trade.

Real trades, newest first

Apr 22 Merle Ferguson Director Open-market sale $534K 26,700,000 sh at $0.02 Sold 100% of stake

Showing every filing. Dashed circles are routine: grants, tax withholding, option exercises and planned sales.

Top holders

Biggest funds in BFNH

No 13F holdings loaded for this stock.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast